[ Price : $8.95]
Forest Laboratories and Gedeon Richter report mixed results from an exploratory Phase 2 trial involving the investigational antips...[ Price : $8.95]
FDA extends by three months its review of an Eisai NDA for eribulin mesylate, indicated for treating locally advanced or metastati...[ Price : $8.95]
A federal indictment accuses three former Spectranetics executives and a fourth person of multiple counts involved in illegally im...[ Price : $8.95]
FDA Webview editor Jim Dickinson reviews the Obama change agenda broadly and finds, from FDA to Afghanistan, that it has delivered...[ Price : $8.95]
CDER oncology drugs director Richard Pazdur says the agency is working on new research guidelines to facilitate development of can...[ Price : $8.95]
FDA grants BioMarin Pharmaceutical Inc. an orphan drug designation for BMN-701, an investigational drug under development for trea...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance, Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for T...[ Price : $8.95]
Federal Register Notice: FDAs Cardiovascular and Renal Drugs Advisory Committee will meet 9/20 to discuss Boehringer Ingelheims ND...